Tonix Pharmaceuticals Holding Corp., A Clinical-Stage Biopharmaceutical Company, Today Announced It Has Entered Into A License Agreement And Extended A Research Collaboration With The University Of Alberta, A Leading Canadian Research University, Focused On Identifying And Testing Broad-Spectrum Antiviral Drugs Against Future Variants Of Sars-Cov-2 And Other Emerging Viruses.
